Skip to main content
All Posts By

admin

Translational Research to Improve Obesity and Diabetes Outcomes (R18) – March 03, 2014

By Uncategorized

Funding Opportunity Number: PAR-12-172
Opportunity Category: Discretionary
Funding Instrument Type: Grant
Category of Funding Activity: Food and Nutrition
Health
CFDA Number: 93.847
Eligible Applicants State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Agency Name: HHS-NIH11
Closing Date: Mar 03, 2014
Award Ceiling:
Expected Number of Awards:
Creation Date: Sep 20, 2013
Funding Opportunity Description: The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) encourages NIH Research Demonstration and Dissemination Project grant (R18) applications from institutions/ organizations to test practical, sustainable, acceptable, and cost efficient adaptations of efficacious strategies or approaches prevent and treat diabetes and/or obesity. Research must target the prevention or reversal of obesity, prevention of type 2 diabetes, improved care of type 1 and type 2 diabetes, or the prevention or delay of the complications of these conditions. The approaches tested should have the potential to be widely disseminated to clinical practice, individuals and communities at risk.

Read more http://www.grants.gov/web/grants/view-opportunity.html?oppId=166853

Read More

NCI Small Grants Program for Cancer Research (NCI Omnibus R03) – Feb 28, 2014

By Uncategorized

Funding Opportunity Number: PAR-12-144
Opportunity Category: Discretionary
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
CFDA Number: 93.393
93.394
93.395
93.396
Eligible Applicants State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Agency Name: HHS-NIH11
Closing Date: Nov 18, 2013
Award Ceiling:
Expected Number of Awards:
Creation Date: Aug 08, 2013
Funding Opportunity Description: This funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI), of the National Institutes of Health (NIH) supports small research projects on cancer that can be carried out in a short period of time with limited resources. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.

Read more http://www.grants.gov/web/grants/view-opportunity.html?oppId=160034

Read More
qi-lily-blog

Giving and Receiving Compliments – Asian Fortune

By News Archive

qi-lily-blog

Something as mundane and common as giving and receiving compliments may be a serious challenge if you are an immigrant.

Over the years, I have learned, often the hard way, the essential importance of receiving and giving compliments, at home, at work, and in social or semi-social environment. Generally speaking, East Asian cultures tend to be more reserved in expressing appreciations or affection toward others compared to the American culture (some generalization here).  We have all heard of such jokes about Asian parents singling out the only “B” in the child’s report card amidst all other “A”s and demand to know why the child had failed to get straight “A”s, while American-born parents would emphasize on the progress or efforts rather than the outcome.

Read More
NewImage

Developers, IT Groups React to FDA’s Mobile Health App Guidance – iHealthBeat

By News Archive

NewImage

Health IT groups and mobile application developers’ reaction to FDA’s release of final guidance for mobile health apps is mixed, the Baltimore Sun reports (Wells/Clarke, Baltimore Sun, 9/23).

Details of Final Rule

According to the final guidance issued Monday, FDA will focus oversight on apps that:

  • Were developed to be used as accessories to regulated medical devices, such as apps that allow health care providers to make diagnoses by viewing medical images on smartphones or tablets; or 
  • Can transform mobile devices into regulated medical devices, such as apps that allow a smartphone to be used as an electrocardiography machine (iHealthBeat, 9/23).
Read More
mobile-tech-sxc

FDA removes roadblocks to medical app innovation – VentureBeat

By News Archive

mobile-tech-sxc

The United States Food and Drug Administration has finally released guidelines on how it plans to regulate thousands of new health-related smartphone applications.

After months of delaying its decision, the agency has determined that the vast majority of these health-related apps pose a negligible threat to consumers. Most of these “mobile medical” apps do not need federal regulation, the FDA found, so developers and investors can breathe a bit easier.

Read More
md-health-tech-coalition

MD HealthTech Coalition (Columbia, MD) – Meetup

By News Archive

md-health-tech-coalition

Wednesday, October 30, 2013
8:30 AM to 11:30 AM

Do you love health technology? Do you want to learn more about it? Do you want to teach others and collaborate with local experts?

Call it what you want–mobile health, digital health, health IT–it’s all about using innovative technology to improve the lives of you, me, and the people we care about. Let’s build an ecosystem dedicated to making health technology part of everyday life and the standard of care! Being located in the Maryland area, we have all the pieces to the puzzle to promote innovation, collaboration, and investment in an industry that will revolutionize healthcare and impact the lives of all 7+ billion people around the world.

Join our ecosystem for the MD HealthTech Coalition Kickoff Event and hear from a panel of experts about the challenges, opportunities, and innovative solutions. More details to follow…

Read More
bwtech-umbc-cyber-incubator

UMBC cyber incubator expansion attracts regional entrepreneurs – Baltimore Business Journal

By News Archive

bwtech-umbc-cyber-incubator

How can you tell Maryland is becoming a hotbed for cyber security business?

Ellen J. Hemmerly said it’s obvious from the companies looking into University of Maryland, Baltimore County’s technology incubator.

“We’re attracting not only local and regional entrepreneurs,” Hemmerly said. “We’re getting more and more inquiries and tenants from out of state.”

Read More
Medimmune logo

MedImmune marks 25th year with reception for founder – Gazette.Net

By News Archive

Medimmune logo

Montgomery County’s largest biotechnology company, which is celebrating its 25th anniversary this week, actually hatched from a meeting in the Big Apple.

In the late 1980s, Wayne T. Hockmeyer was an executive with Praxis Biologics in Rochester, N.Y., with an inkling to branch out on his own. He had spent two decades in the U.S. Army, including as chairman of the Department of Immunology at Walter Reed Army Institute of Research in Washington, D.C., from 1980 to 1986.

Read More
jhu-umd-bayview-campus-image

Johns Hopkins and University of Maryland to build research and science center in East Baltimore

By News Archive

jhu-umd-bayview-campus-image

The state’s two major research institutions, Johns Hopkins University and the University of Maryland, College Park , are partnering to build a research and science center in East Baltimore opening September 2014. The state is spending $27 million and Hopkins is contributing $3 million toward the $30 million public/private venture whose goal is to make Maryland’s universities and private industry more competitive in the sciences.

The High Performance Research Computing Facility will consist of multiple buildings on land leased from Hopkins on its 350-acre Bayview Medical campus, at 4940 Eastern Ave. Expected to break ground in November, the center will be set off from other buildings and have its own separate entrance. The universities will finish site design this month and then bid the project to vendors. 

Read More
glaxosmithkline

GSK signs agreement with BARDA for anthrax treatment – BioPrepWatch.com

By News Archive

glaxosmithkline

GlaxoSmithKline announced on Thursday that it has signed a four-year contract with the Biomedical Advanced Research and Development Authority for the provision of its inhalation anthrax treatment, raxibacumab.

In the new contract, GSK will give the United States government 60,000 doses of raxibacumab over a four year period. The estimated value of these shipments total $196 million.

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.